Longtime Epstein-linked activist Peter Attia quits David Protein, and his foundations ‘will not respond’

Founder of David Protein, a manufacturer of high-protein nutritional supplements, he announced on X Monday that longevity expert Dr. Peter Attia has “stepped down from his role as Chief Science Officer at David.”

The announcement comes after Attia’s name appeared in more than 1,700 documents, including e-mails, that were released on Friday as part of a large-scale leaked file related to convicted sex offender Jeffrey Epstein. according to The New York Times. Attia served on the executive board of the food startup and was Early investors.

For those who don’t know, Attia is a Canadian-American physician who has become one of the leading voices on longevity and wellness. He is best known for his best-selling book “Outlive: The Science and Art of Longevity” and his seven-year-old podcast, in which he looks at ways to achieve it. He was also hired last month as an assistant at CBS.

Three-year-old David Protein, based in New York, raised $75 million in Series A funding in May last year led by Greenoaks, backed by Valor Equity Partners. The company has grown significantly since launching its protein bar in September 2024, a product it claims has 28 grams of protein, zero sugar, and 150 calories.

At length post on XAttia wrote that she was “embarrassed” by some of the sleazy things she wrote with Epstein, but added that she was not involved in crime and had never visited Epstein’s island or boarded a plane. Attia also discussed in depth how she got to know Epstein and why she stayed with him even after Epstein’s death. 2008 objection.

The fallout seems to be continuing for David Protein. It also appears that Biograph, the health testing and longevity startup that Attia founded with entrepreneur John Hering, may be distancing itself from the doctor. The company declined to comment on Attia’s actions and resumes or the pages on its website that mention him but now drop his name or return a “file not found” error.

Biograph came out in secret a year ago, TechCrunch previously reportedbacked by investors including Vy Capital, Human Capital, Alpha Wave, and WndrCo, along with angel investors including Balaji Srinivasan. Like most medical aid companies, Biograph offers preventative health care to subscribers who pay between $7,500 and $15,000 a year. Attia was mentioned earlier on press release and places like co-founded.